<DOC>
	<DOC>NCT02904265</DOC>
	<brief_summary>The purpose of this study is to compare the effectiveness of the medications acetazolamide and diazepam in the treatment of continuous spike wave in sleep (CSWS) and Landau-Kleffner syndrome (LKS).</brief_summary>
	<brief_title>Efficacy Study of Acetazolamide Versus Diazepam in Continuous Spike and Wave/Landau-Kleffner Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Status Epilepticus</mesh_term>
	<mesh_term>Landau-Kleffner Syndrome</mesh_term>
	<mesh_term>Acetazolamide</mesh_term>
	<mesh_term>Diazepam</mesh_term>
	<criteria>ESES and clinical CSWS/LKS defined by all of the following: SWI ≥50% during first hour of sleep Bilateral synchrony of discharges during sleep Clinical evidence of behavior and/or academic regression Daytime SWI ≤20% Previous treatment with benzodiazepine or acetazolamide for Electrical Status Epilepticus in Sleep (ESES) Current treatment with carbamazepine, phenytoin, oxcarbazepine, phenobarbital, vigabatrin or lamotrigine Antiepileptic medication changes over the month prior to enrollment Epileptic encephalopathy other than CSWS/LKS Prior serious adverse reaction to benzodiazepines or acetazolamide Sulfa allergy Progressive underlying neurologic condition Frequent seizures that would prevent the patient from maintaining a stable dose of medications Female patient that has begun menses or is pregnant</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>continuous spike wave in sleep</keyword>
	<keyword>Landau-Kleffner syndrome</keyword>
	<keyword>acetazolamide</keyword>
	<keyword>diazepam</keyword>
</DOC>